Biopharmaceutical
Pharmaceutical
Health
AbbVie
$80.579876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$80.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.09 (-1.34%) Today
+$0.51 (0.64%) After Hours
Why Robinhood?
You can buy or sell AbbVie and other stocks, options, ETFs, and crypto commission-free!
About
ABBVIE INC., also called AbbVie, is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. Read More The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.
Employees
30,000
Headquarters
North Chicago, Illinois
Founded
2013
Market Cap
118.35B
Price-Earnings Ratio
22.94
Dividend Yield
4.28
Average Volume
6.59M
High Today
$81.10
Low Today
$79.87
Open Price
$81.09
Volume
1.16M
52 Week High
$103.16
52 Week Low
$75.62
Collections
Biopharmaceutical
Pharmaceutical
Health
Manufacturing
Cancer Prevention
Technology
2013 IPO
US
News
Yahoo FinanceMay 24
Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates
The biggest news this week was Merck’s MRK offer to buy small cancer biotech Peloton Therapeutics, which will add a late-stage kidney cancer candidate to its oncology pipeline.
Yahoo FinanceMay 22
Top Ranked Income Stocks to Buy for May 22nd
Here are three stocks with buy rank and strong income characteristics for investors to consider today, May 22nd: The Buckle, Inc. (BKE): This retailer of casual apparel, footwear and accessories has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.1% over the last 60 days. Buckle, Inc. (The) Price and Consensus Scroll to continue with content Ad Buckle, Inc. (The) Price and Consensus Buckle, Inc. (The) price-consensus-chart | Buckle, Inc. (The) Quote This Zacks Rank #1...
Price Paid on Robinhood
8% Lower
Right Now
52 Week Low
$75.62
Average Price Paid
$87.17
52 Week High
$103.16
Earnings
$1.38
$1.63
$1.89
$2.14
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Jul 26, Pre-Market